Department of Urology, Reims University Hospital, Reims, France.
Department of Urology, Nancy University Hospital, Nancy, France.
Int J Clin Oncol. 2024 Oct;29(10):1509-1515. doi: 10.1007/s10147-024-02578-0. Epub 2024 Jul 9.
The aim of the study was to determine the impact of positive surgical margins (PSM) after PN on very long-term recurrence in a contemporary cohort.
Patients who underwent PN for a localized renal tumour were included. Patients were stratified according to the presence of PSM. Data on patients' characteristics, the tumour, the peri- and postoperative events were collected. Disease-free survival (DFS) and overall survival (OS) were assessed by the Kaplan-Meier method and compared by the log-rank test. Sensitivity analyses using weighted propensity score analysis was performed to account for potential selection biases arising from the nonrandom allocation of patients to different groups.
A total of 1115 patients were included in the study. The incidence of PSM was 5.4% (n = 61). The median follow-up time was 51 months for the PSM group and 61 months for the NSM group (p = 0.31). Recurrence rates were significantly higher in the PSM group (13%, n = 8) compared to the NSM group (7%, n = 73) (p = 0.05). This resulted in a significant reduction in DFS in the PSM group (p = 0.004), particularly pronounced in patients with clear cell renal cell carcinoma. Additionally, OS was significantly lower in the PSM group (p < 0.01). Propensity score analysis confirmed a decrease in DFS for the PSM group (p = 0.05), while there was no significant difference in OS between the two groups (p = 0.49).
In this retrospective multicenter study, PSM impact on oncological outcomes, increasing recurrence, but no difference in OS was observed post-adjustment for biases.
本研究旨在确定局部肾肿瘤患者行 PN 后阳性切缘(PSM)对极长期复发的影响。
纳入行 PN 治疗局限性肾肿瘤的患者。根据是否存在 PSM 对患者进行分层。收集患者特征、肿瘤、围手术期事件等数据。采用 Kaplan-Meier 法评估无病生存(DFS)和总生存(OS),并用对数秩检验比较。采用加权倾向评分分析进行敏感性分析,以纠正患者分组中潜在的非随机选择偏倚。
共纳入 1115 例患者。PSM 的发生率为 5.4%(n=61)。PSM 组和 NSM 组的中位随访时间分别为 51 个月和 61 个月(p=0.31)。PSM 组的复发率(13%,n=8)显著高于 NSM 组(7%,n=73)(p=0.05)。这导致 PSM 组的 DFS 显著降低(p=0.004),在透明细胞肾细胞癌患者中更为明显。此外,PSM 组的 OS 显著降低(p<0.01)。倾向评分分析证实 PSM 组的 DFS 降低(p=0.05),而两组间 OS 无显著差异(p=0.49)。
在这项回顾性多中心研究中,PSM 对肿瘤学结果有影响,增加了复发的风险,但在调整了偏倚后,OS 没有显著差异。